Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-03-20
1992-09-08
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
051458594
ABSTRACT:
According to the invention there is provided various methods of treating mammalian interstitial cystitis and/or urethral syndrome through the use of Nifedipine, a calcium channel antagonist which has been primarily used for the treatment of coronary artery spasms and hypertension. Specifically, the invention is directed to the adminstration of an therapeutically effective amount of Nifedipine to mammals suffering from interstitial cystitis and/or urethral syndrome. The Nifedipine may be administered in admixture with a pharmaceutically acceptable carrier in a unit dosage form. The route of administration is that deemed preferred by the attending physician, with oral administration being preferred.
REFERENCES:
patent: 4268518 (1981-05-01), Turner
patent: 4412986 (1983-11-01), Kawata et al.
patent: 4690935 (1987-09-01), Taylor et al.
patent: 4696934 (1987-09-01), Marcoux
patent: 4728660 (1988-03-01), Haynes et al.
patent: 4749714 (1988-06-01), Gross et al.
patent: 4765990 (1988-08-01), Sugimoto et al.
patent: 4776081 (1988-09-01), Doi et al.
patent: 4778798 (1988-10-01), Brasey
patent: 4800081 (1989-01-01), Albreich et al.
patent: 4814175 (1989-03-01), Tack et al.
patent: 4855300 (1989-08-01), Nandi et al.
patent: 4869899 (1989-09-01), Burghart et al.
patent: 4871545 (1989-10-01), Dethlefsen
patent: 4874774 (1989-10-01), Ushimaru et al.
patent: 4877791 (1989-10-01), Sherman
patent: 4880623 (1989-11-01), Piergiorgio et al.
patent: 4892730 (1990-10-01), Hegasy
patent: 4894235 (1990-01-01), Kohne et al.
patent: 4904699 (1990-02-01), Bauer
Gillenwater, et al., Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshops on Interstitial Cystitis, National Institutes of Health, Bethesda, Md, Aug. 28-29, 1987, The Journal of Urology, vol. 140, pp. 203-206, Jul. 1988.
Harvey L. Gordon, et al., Immunologic Aspects of Interstitial Cystitis, The Journal of Urology, vol. 109, pp. 228-233, Feb. 1972.
Philip Hanno, et al., Diagnosis of Interstitial Cystitis, The Journal of Urology, vol. 143, pp. 278-281, Feb. 1989.
J. D. Fleischmann, et al., Measurement and Partial Characterization of an Interleukin-2 Inhibitor (IL-2-IN) In Human Urine, Journal of Biological Regulators and Homeostatic Agents, vol. 4, No. 2, pp. 73-80, Apr. 1990.
W. Bruce Shingleton, et al., Urinary Interleukin-2 Inhibitor and the Voiding Symptoms in Female Patients with Interstitial Cystitis, Seminars in Urology, vol. IX, No. 2, pp. 001-005, May 1991.
M. A. Zar, et al., Effect of Nifedipine on the Contractile Responses of the Isolater Rat Bladder, The Journal of Urology, vol. 143, pp. 835-839, Apr.
Deborah L. Birx, et al., The Interference of T Cell Activation by Calcium Channel Blocking Agents, the Journal of Immunology, vol. 133, No. 6, pp. 2904-2909, Dec. 1984.
Quintina Corteza, et al., Effects of Calcium Channel Blockers in Vivo Cellular Immunity in Mice, Transplantation, vol. 47, No. 2, pp. 339-342, Feb. 1989.
Steven Gillis, et al., T Cell Growth Factor: Paramets of Production and a Quantitative Microassay for Activity, The Journal of Immunology, vol. 120, No. 6, pp. 2027-2032, Jun. 1978.
Kazuo Kasugami, et al., Intestinal Immune Reactivity to Interleukin 2 Differs among Chrohn's Disease, Ulcerative Colitis, and Controls, Gastroenterology, vol. 97, No. 1, pp. 1-9, Jul. 1989.
Joel E. Richter, et al., Oral Nifedipine in the Treatment of Noncardiac Chest Pain in Patients with the Nutcracker Esophagus, Gastroenterology, vol. 93, No. 1, pp. 21-28, Jul. 1987.
Peter H. Stone, M.D., et al., Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part II: Hemodynamic Effects and Clinical Applications, Annals of Internal Medicine, vol. 93, No. 6, pp. 886-904, Dec. 1980.
Sami Viskin, M.D., et al., Nifedipine and Ureteral Colic, Annals of Internal Medicine, vol. 105, No. 1, p. 142, Jul. 1986.
A. Tapp, et al., Terodiline: a Dose Titrated, Multicenter Study of the Treatment of Idiopathic Detrusor Instability in Women, the Journal of Urology, vol. 142, pp. 1027-1031, Oct. 1989.
Ramon Perez-Marrero, M.D., et al., Urodynamic Studies in Interstitial Cystitis, Supplement to Urology, vol. XXIX, No. 4, pp. 27-30, Apr. 1987.
Philip M. Hanno, M.D., et al., Medical Treatment of Interstitial Cystitis (Other than Rimso-50/Elmiron), Supplement to Urology, vol XXIX, No. 4, pp. 22-27, Apr. 1987.
Kerstin M. Kindahl-Kiessling, Calcium Dependency of the Binding and Mitogenicity of Phytohemagglutinin, Experimental Cell Research 103, pp. 151-157, 1976.
Gustav, J. V. Nossal, M.D., Ph.D., The Basic Components of the Immune System, The New England Journal of Medicine, pp. 1320-1325, May 21, 1987.
Jonathan D. Fleischmann, M.D., et al., Urinary Interleukins in Patients Receiving Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer, Cancer, vol. 64, No. 7, pp. 1447-1454, Oct. 1, 1989.
J. D. Fleischmann, M.D., et al., Urinary Interleukin-2 Inhibition in Patients with Cystitis, Immunological Investigations, vol. 18, No. 6, pp. 824-831, 1989.
N. T. M. Galloway, et al., Interstitial Cystitis: A Form of Reflex Sympathetic Dystrophy?, In Press.
Robert G. Chuinard, M.D., et al., Intravenous Reserpine for Treatment of Reflex Sympathetic Dystrophy, Southern Medical Journal, vol. 74, No. 12, pp. 1481-1484, Dec. 1981.
Steven R. Ford, M.D., et al., The Treatment Oraflex Sympathetic Dystrophy with Intravenous Regional Bretylium, Anestesiology, vol. 68, No. 1, pp. 137-140, Jan. 1988.
William T. Hyland, M.D., Treating Reflex Sympathetic Dystrophy with Transdermal Nitroglycerin, Correspondence, vol. 83, No. 1, p. 195.
Peters, D. et al., Scand J Urol Nephrol Suppl 87(Suppl):21-33 1984.
Susset, J. et al, J Urol 141(2):408-13 1989.
Ogawa, A. et al, Hinyikika Kiyo 34(4): 739-53 1988.
Nakano, M. et al, Hinyokika Kiyo 34(1): 196-200 1988.
Kontani, H. et al, Japan J Pharmacol 53: 427-433 1990.
Case Western Reserve University
Gardner Diane
Waddell Frederick E.
LandOfFree
Methods of treating interstitial cystitis and urethral syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating interstitial cystitis and urethral syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating interstitial cystitis and urethral syndrome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-134530